Navigation Links
GeneTex to Release New Antibodies for the Study of DNA Repair in Zebrafish
Date:3/14/2013

IRVINE, Calif., March 14, 2013 /PRNewswire/ -- GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that it will be launching new antibodies against phosphorylated Histone H2A.X and p53 designed for use with zebrafish samples.

(Photo: http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b)

The zebrafish is being increasingly utilized as a model organism to study DNA repair. The zebrafish genome contains nearly all of the genes involved in the different DNA repair pathways, including the genes for the components of the p53-mediated damage recognition pathway. Furthermore, the embryos can easily be treated with UV or ionizing irradiation to induce DNA damage.  Importantly, the study of individual DNA damage recognition and repair factors is possible with shRNA- or morpholino-based approaches that are established techniques in the zebrafish field.

GeneTex is excited to contribute to zebrafish DNA damage recognition and repair research by offering these two new antibodies. Phosphorylated histone H2A.X is extremely useful as an early marker of double-strand breaks that can be used to assess the extent of DSB repair. The p53 antibody will be immensely valuable for those researchers studying DNA damage and apoptotic mechanisms, with the logical extension into tumorigenesis. These two reagents represent just the beginning of GeneTex's efforts to establish a diverse catalog of antibody products that perform in the zebrafish system. Therefore, GeneTex is pleased to announce the launch of these new antibodies against phosphorylated H2A.X and p53 that have been developed specifically for use with zebrafish.

GeneTex's Histone H2A.X (phospho Ser139) antibody has been validated for immunohistochemistry using both whole-mount and paraffin-embedded zebrafish embryos. The p53 antibody has been validated for western blotting and immunohistochemistry using zebrafish tissues. UV irradiation results in a marked increase in the intensity of the signal detected by both products, which demonstrates the specificity of these antibodies. For additional information on GeneTex, Inc. and its zebrafish antibodies, please call toll-free 877-GENETEX (436-3839) or visit www.genetex.com/zebrafish.

About GeneTex, Inc.

GeneTex, Inc. is an antibody company founded in 1997 by a group of internationally renowned academic scientists. They strive to produce the highest-quality antibodies and reagents. Their primary and secondary antibodies are created through a process involving extensive research, development and validation.  GeneTex's catalog has grown to over 55,000 primary antibodies and all are backed by a 100% Satisfaction Guarantee. 

Corporate Mission

We strive to serve and accelerate life science research by creating essential life science tools where quality can be found in every vial.


'/>"/>
SOURCE GeneTex
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GeneTex, Inc. to Launch a New Primary Antibody against HIF1a
2. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
3. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
4. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
5. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
6. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
7. ShelfX Releases A Fridge That Knows What You Took
8. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
9. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
10. Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System
11. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 15, 2012; Conference Call set for 3:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Feb. 10, 2016 CSI Specialty Group (CSI) ... launch of the Specialty Pharmacy Podcast. A free, weekly ... at providing real-world education, discussion and context amongst specialty ... --> The Specialty Pharmacy Podcast, ... CSI Specialty Group Suzette DiMascio, CHE, CMCE, CPC, is ...
(Date:2/10/2016)... MINNEAPOLIS , Feb. 10, 2016 Urologix, ... for the treatment of Benign Prostatic Hyperplasia (BPH), announces ... Ash Keswani , a medical device industry veteran ... of the Limited Liability Company.  ... and service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... 2016 , ... A national ergonomics pioneer , HealthPostures, ... March 9-11, 2016. Hosted by Ohio's Bureau of Worker's Compensation, the expo will ... running and largest worker's compensation event in Ohio, organizers of the safety congress ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has ... readily available to physicians. The integration will enable Allscripts users to post ... via Everseat’s free mobile app. , The partnership gives Everseat substantial added power ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - ... - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... based company that has evolved from humble beginnings to being an internationally recognized leader ... company that we are today”, said Charlie Lawrence, President of Workrite. “Workrite recognized ...
Breaking Medicine News(10 mins):